SBT777101

Sonoma Biotherapeutics, Inc. · Phase 1 active Biologic

At a glance

Generic name	SBT777101
Sponsor	Sonoma Biotherapeutics, Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa (PHASE1)
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SBT777101 CI brief — competitive landscape report
SBT777101 updates RSS · CI watch RSS
Sonoma Biotherapeutics, Inc. portfolio CI